Issue directions to the Union of India to Compensate the People who are severely disabled or died because of the side effects of Corona vaccine administered to them during Covid 19.” A plea has ...
Gennova mrna-based vaccine: India's first mRNA vaccine GEMCOVAC-19 has got emergency use authorization. The Drugs Controller General of India (DCGI) gave its go ahead to the two-dose mrna-based ...
Cyrus Poonawalla is a prominent figure in vaccine development in India and the primary beneficiary of the expanding sales and earnings of the privately held Serum Institute of India. His son ...
10 天on MSN
As of December 2024, the swine flu (H5N1) outbreak has infected approximately 20,414 people and caused around 347 fatalities.
The government of India has decided to give COVID booster doses to all above 18 years. Corbevax COVID-19 Vaccine is India's first indigenously developed RBD protein sub-unit vaccine against COVID-19.
Union Minister Prataprao Jadhav announced that a cancer vaccine for breast, oral, and cervical cancers in women will be available in India within five to six months. Girls aged nine to 16 years ...
The Karnataka High Court on Monday (March 10) disposed of a 2022 petition filed by one Vinod Kumar M N seeking a direction to the authorities to give him a second dose of Covid vaccine.
for the early stage research and development of a six-in-one combination paediatric vaccine to help protect children in India and other developing countries from polio and other infectious diseases.
ICMR initiated the work after a request from the Karnataka government. “India is developing the vaccine for Kyasanur Forest Disease (KFD)," said Dr Rajiv Bahl, director general, ICMR ...
India is making significant strides in its battle against Kyasanur Forest Disease (KFD), commonly known as Monkey Fever, by developing its first indigenously produced vaccine. This crucial ...
The Union Minister of State for Health, Family Welfare, and Ayush (Independent Charge) stated at a news conference held here that vaccine research is almost finished and trials are in progress.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果